clinical trials

Are Clinical Trials Really That Costly? These Researchers Say They Don’t Have to Be
Are Clinical Trials Really That Costly? These Researchers Say They Don’t Have to Be
Xtalks
clinical trials
Flag link:
Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial
Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial
Fierce Biotech
Aldeyra Therapeutics
dry eye disease
clinical trials
reproxalap
Flag link:
Reata’s bardoxolone hits goals in phase 2 kidney disease trial
Reata’s bardoxolone hits goals in phase 2 kidney disease trial
Fierce Biotech
Reata
kidney disease
Bardoxolone
clinical trials
Flag link:
J&J's Esketamine Fails to Meet Endpoint in Phase III Study
J&J's Esketamine Fails to Meet Endpoint in Phase III Study
Yahoo/Zacks.com
JNJ
clinical trials
esketamine
treatment-resistant depression
Flag link:
Phase 3 Trial Costs Estimated at $19M, Study Finds
Phase 3 Trial Costs Estimated at $19M, Study Finds
RAPS.org
clinical trials
Flag link:
Alexion’s Soliris wows in rare disease PhIII trial, opening up a new franchise worth $500M-$700M
Alexion’s Soliris wows in rare disease PhIII trial, opening up a new franchise worth $500M-$700M
Endpoints
Alexion
Soliris
clinical trials
NMOSD
Flag link:
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
CP Wire
AstraZeneca
Farxiga
Dapagliflozin
clinical trials
type 2 diabetes
cardiovascular disease
Flag link:
FDA lifts clinical hold on Sarepta's Duchenne MD gene therapy, clearing the way to a quick launch of a pivotal trial
FDA lifts clinical hold on Sarepta's Duchenne MD gene therapy, clearing the way to a quick launch of a pivotal trial
Endpoints
Sarepta Therapeutics
FDA
gene therapy
Duchenne Muscular Dystrophy
clinical trials
Flag link:
FDA gives Epizyme a green light on trial recruitment, but tazemetostat isn’t completely out of the woods yet
FDA gives Epizyme a green light on trial recruitment, but tazemetostat isn’t completely out of the woods yet
Endpoints
Epizyme
clinical trials
FDA
tazemetostat
Flag link:
FDA may crack down on clinical trial reporting
FDA may crack down on clinical trial reporting
BioCentury
FDA
clinical trials
clinical trial data
Flag link:
Roche tackles clinical trial matching challenge
Roche tackles clinical trial matching challenge
Fierce Biotech
Roche
clinical trials
patients
physicians
Flag link:
Allergan, Sosei halt Alzheimer’s trials amid safety scare
Allergan, Sosei halt Alzheimer’s trials amid safety scare
Fierce Biotech
Allergan
Sosei
HTL0018318
clinical trials
Alzheimer's disease
Flag link:
Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment
Promising study results thrust Viking Therapeutics into race for lucrative fatty liver disease treatment
Stat
Viking Therapeutics
NASH
non-alcoholic fatty liver disease
VK2809
clinical trials
Flag link:
Researchers launch early-stage trial for nasal flu vaccine
Researchers launch early-stage trial for nasal flu vaccine
Drug Delivery Business News
flu vaccines
vaccines
pediatrics
nasal flu vaccine
FluGen
clinical trials
Flag link:
Harvard Professor's Attack On Pharma's Clinical Trials Is Absurd
Harvard Professor's Attack On Pharma's Clinical Trials Is Absurd
Forbes
Harvard
clinical trials
New England Journal of Medicine
Flag link:
Pfizer’s JAK inhibitors improve hair regrowth in patients with alopecia areata
Pfizer’s JAK inhibitors improve hair regrowth in patients with alopecia areata
Pharmaceutical Business Review
Pfizer
JAK inhibitors
alopecia areata
clinical trials
PF-06651600
PF-06700841
Flag link:
After back-to-back trial flops, Realm slashes its staff, halts research work and ponders a fire sale
After back-to-back trial flops, Realm slashes its staff, halts research work and ponders a fire sale
Endpoints
Realm Therapeutics
atopic dermatitis
clinical trials
layoffs
Flag link:
FDA lifts clinical hold from Mersana’s breast cancer trial
FDA lifts clinical hold from Mersana’s breast cancer trial
Fierce Biotech
FDA
clinical trials
Mersana
antibody-drug conjugate
XMT-1522
breast cancer
Flag link:
Bone Therapeutics’ cell therapy hits goal in phase 1/2a, but manufacturing changes slow progress
Bone Therapeutics’ cell therapy hits goal in phase 1/2a, but manufacturing changes slow progress
Fierce Biotech
Bone Therapeutics
cell therapy
ALLOB
clinical trials
Flag link:
Half of Europe's clinical trials fail to report results despite EU rule
Half of Europe's clinical trials fail to report results despite EU rule
Reuters
Europe
clinical trials
Flag link:

Pages